SVWAG
ABBV icon

Sound View Wealth Advisors Group’s AbbVie ABBV Stock Holding History

Sound View Wealth Advisors Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Buy
53,079
+290
+0.5% +$64.3K 0.79% 33
2025
Q4 		$12.1M Sell
52,789
-640
-1% -$146K 0.81% 31
2025
Q3 		$12.4M Sell
53,429
-1,506
-3% -$307K 0.85% 33
2025
Q2 		$10.2M Buy
54,935
+82
+0.1% +$15.2K 0.75% 34
2025
Q1 		$11.5M Sell
54,853
-3,959
-7% -$770K 0.94% 27
2024
Q4 		$10.5M Buy
58,812
+1,436
+3% +$264K 0.84% 32
2024
Q3 		$11.3M Buy
57,376
+3,352
+6% +$626K 0.92% 28
2024
Q2 		$9.27M Sell
54,024
-218
-0.4% -$36.1K 0.96% 28
2024
Q1 		$9.88M Sell
54,242
-2,415
-4% -$416K 1.05% 25
2023
Q4 		$8.78M Buy
56,657
+459
+0.8% +$66.9K 0.97% 25
2023
Q3 		$8.38M Buy
56,198
+2,320
+4% +$341K 1.04% 25
2023
Q2 		$7.26M Buy
53,878
+766
+1% +$112K 0.95% 28
2023
Q1 		$8.46M Sell
53,112
-3,545
-6% -$542K 1.16% 18
2022
Q4 		$8.78M Buy
56,657
+15,208
+37% +$2.33M 0.97% 25
2022
Q3 		$5.56M Sell
41,449
-374
-0.9% -$53.7K 1.25% 19
2022
Q2 		$6.41M Buy
41,823
+469
+1% +$71.7K 1.34% 18
2022
Q1 		$6.7M Sell
41,354
-780
-2% -$113K 1.27% 19
2021
Q4 		$5.71M Buy
42,134
+277
+0.7% +$32.7K 1.08% 23
2021
Q3 		$4.51M Sell
41,857
-2,161
-5% -$247K 0.94% 32
2021
Q2 		$4.96M Sell
44,018
-601
-1% -$67.7K 1.04% 26
2021
Q1 		$4.83M Sell
44,619
-89
-0.2% -$9.52K 1.12% 23
2020
Q4 		$4.79M Buy
44,708
+37
+0.1% +$3.56K 1.17% 23
2020
Q3 		$3.91M Sell
44,671
-318
-0.7% -$29.9K 1.03% 27
2020
Q2 		$4.42M Sell
44,989
-254
-0.6% -$22.4K 1.24% 21
2020
Q1 		$3.45M Buy
45,243
+1,700
+4% +$145K 1.19% 24
2019
Q4 		$3.85M Sell
43,543
-139
-0.3% -$11.5K 1.09% 28
2019
Q3 		$3.31M Buy
43,682
+12,673
+41% +$869K 0.99% 32
2019
Q2 		$2.25M Buy
+31,009
New +$2.44M 0.67% 48

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sound View Wealth Advisors Group's ABBV Position: Q1 2026 in Review

Sound View Wealth Advisors Group increased its AbbVie (ABBV) stake by 0.55% in Q1 2026, buying an estimated $64.3K and bringing the position to 53,079 shares worth $11.5M. The position accounts for 0.79% of the portfolio, ranked #33.

Sound View Wealth Advisors Group first reported a position in ABBV in Q2 2019 and has held it in 28 quarters since. The position peaked at $12.4M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Sound View Wealth Advisors Group held 53,079 shares of AbbVie worth $11.5M as of Q1 2026.
  • Sound View Wealth Advisors Group bought 290 AbbVie shares in Q1 2026, an estimated $64.3K.
  • AbbVie made up 0.79% of Sound View Wealth Advisors Group's portfolio in Q1 2026, its #33 holding.
  • Sound View Wealth Advisors Group first reported a position in AbbVie in Q2 2019 and has held it in 28 quarters since.
  • Sound View Wealth Advisors Group's AbbVie position peaked at $12.4M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q1 2026, filed 6 May 2026.